Virulence genes of Helicobacter pylori in the Dominican Republic

Journal of Medical Microbiology

Volumn 63, Issue PART 9, 2014, Pages 1189-1196

  Shiota, Seiji ^a   Cruz, Modesto ^b,c   Abreu, José A Jiménez ^d   Mitsui, Takahiro ^a   Terao, Hideo ^a   Disla, Mildre ^e   Iwatani, Shun ^a,f   Nagashima, Hiroyuki ^a,f   Matsuda, Miyuki ^a   Uchida, Tomohisa ^a   Tronilo, Lourdes ^d   Rodríguez, Eduardo ^d   Yamaoka, Yoshio ^a,f  

^a OITA UNIVERSITY   (Japan)

^b Universidad Autónoma de Santo Domingo   (Dominican Republic)

^c UNIVERSIDAD TECNOLÓGICA DE SANTIAGO   (Dominican Republic)

^d Dominican Japanese Digestive Disease Center Dr Luis E Aybar Health and Hygiene City   (Dominican Republic)

^e Department of Public Health   (Dominican Republic)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; VACUOLATING TOXIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; DOMINICAN REPUBLIC; FEMALE; GASTRITIS; GENE SEQUENCE; GENETIC ANALYSIS; GROUPS BY AGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RAPID UREASE TEST; STOMACH CANCER; STOMACH MUCOSA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DOMINICAN REPUBLIC; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84906842104     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.075275-0     Document Type: Article

References (62)

1. Aoki, K., Kihaile, P. E., Castro, M., Disla, M., Nyambo, T. B. & Misumi, J. (2004). Seroprevalences of Helicobacter pylori infection and chronic zatrophic gastritis in the United Republic of Tanzania and the Dominican Republic. Environ Health Prev Med 9, 170-175
2. Aoki, K., Kihaile, P. E., Wenyuan, Z., Xianghang, Z., Castro, M., Disla, M., Nyambo, T. B. & Misumi, J. (2005). Comparison of prevalence of chronic atrophic gastritis in Japan, China, Tanzania, and the Dominican Republic. Ann Epidemiol 15, 598-606
3. Argent, R. H., Kidd, M., Owen, R. J., Thomas, R. J., Limb, M. C. & Atherton, J. C. (2004). Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127, 514-523
4. Asaka, M., Kimura, T., Kudo, M., Takeda, H., Mitani, S., Miyazaki, T., Miki, K. & Graham, D. Y. (1992). Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 102, 760-766
5. Asaka, M., Kato, M., Takahashi, S., Fukuda, Y., Sugiyama, T., Ota, H., Uemura, N., Murakami, K., Satoh, K., Sugano, K. & Japanese Society for Helicobacter Research (2010). Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 15, 1-20
6. Atherton, J. C., Cao, P., Peek, R. M., Jr, Tummuru, M. K., Blaser, M. J. & Cover, T. L. (1995). Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270, 17771-17777
7. Azevedo, N. F., Huntington, J. & Goodman, K. J. (2009). The epidemiology of Helicobacter pylori and public health implications. Helicobacter 14 (Suppl 1), 1-7
8. Azuma, T., Yamakawa, A., Yamazaki, S., Fukuta, K., Ohtani, M., Ito, Y., Dojo, M., Yamazaki, Y. & Kuriyama, M. (2002). Correlation between variation of the 39 region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J Infect Dis 186, 1621-1630
9. Bornschein, J., Selgrad, M., Wex, T., Kuester, D. & Malfertheiner, P. (2012). Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol 12, 10
10. Brenner, H., Rothenbacher, D. & Weck, M. N. (2007). Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value. Int J Cancer 121, 2782-2786
11. Burucoa, C., Delchier, J. C., Courillon-Mallet, A., de Korwin, J. D., Mégraud, F., Zerbib, F., Raymond, J. & Fauchère, J. L. (2013). Comparative evaluation of 29 commercial Helicobacter pylori serological kits. Helicobacter 18, 169-179
12. Calvet, X., Ramírez Lázaro, M. J., Lehours, P. & Mégraud, F. (2013). Diagnosis and epidemiology of Helicobacter pylori infection. Helicobacter 18 (Suppl 1), 5-11
13. Covacci, A., Censini, S., Bugnoli, M., Petracca, R., Burroni, D., Macchia, G., Massone, A., Papini, E., Xiang, Z. & other authors (1993). Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A 90, 5791-5795
14. Cover, T. L. & Blaser, M. J. (1992). Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 267, 10570-10575
15. Dattoli, V. C., Veiga, R. V., da Cunha, S. S., Pontes-de-Carvalho, L. C., Barreto, M. L. & Alcântara-Neves, N. M. (2010). Seroprevalence and potential risk factors for Helicobacter pylori infection in Brazilian children. Helicobacter 15, 273-278
16. Dixon, M. F., Genta, R. M., Yardley, J. H. & Correa, P. (1996). Classification and grading of gastritis: the updated Sydney System. Am J Surg Pathol 20, 1161-1181
17. Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C. & Parkin, D. M. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127, 2893-2917
18. Goh, K. L., Chan, W. K., Shiota, S. & Yamaoka, Y. (2011). Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 16 (Suppl 1), 1-9
19. Hisada, M., Lee, M. G., Hanchard, B., Owens, M., Song, Q., van Doorn, L. J., Cutler, A. F. & Gold, B. D. (2001). Characteristics of Helicobacter pylori infection in Jamaican adults with gastrointestinal symptoms. J Clin Microbiol 39, 212-216
20. Huang, J. Q., Sridhar, S. & Hunt, R. H. (2002). Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in pepticulcer disease: a meta-analysis. Lancet 359, 14-22
21. Kodama, M., Murakami, K., Okimoto, T., Abe, T., Nakagawa, Y., Mizukami, K., Uchida, M., Inoue, K. & Fujioka, T. (2012a). Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation. Digestion 85, 126-130
22. Kodama, M., Murakami, K., Okimoto, T., Sato, R., Uchida, M., Abe, T., Shiota, S., Nakagawa, Y., Mizukami, K. & Fujioka, T. (2012b). Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol 47, 394-403
23. Leja, M., Cine, E., Rudzite, D., Vilkoite, I., Huttunen, T., Daugule, I., Rumba-Rozenfelde, I., Pimanov, S., Liepniece-Karele, I. & other authors (2012). Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia. Eur J Gastroenterol Hepatol 24, 1410-1417
24. Leung, W. K., Wu, M. S., Kakugawa, Y., Kim, J. J., Yeoh, K. G., Goh, K. L., Wu, K. C., Wu, D. C., Sollano, J. & other authors (2008). Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 9, 279-287
25. Malaty, H. M. (2007). Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 21, 205-214
26. Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y. & other authors (2012). Management of Helicobacter pylori infection - the Maastricht IV/Florence Consensus Report. Gut 61, 646-664
27. Matsuda, M., Shiota, S., Matsunari, O., Watada, M., Murakami, K., Fujioka, T. & Yamaoka, Y. (2011). Prevalence of two homologous genes encoding glycosyltransferases of Helicobacter pylori in the United States and Japan. J Gastroenterol Hepatol 26, 1451-1456
28. Matsunari, O., Shiota, S., Suzuki, R., Watada, M., Kinjo, N., Murakami, K., Fujioka, T., Kinjo, F. & Yamaoka, Y. (2012). Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J Clin Microbiol 50, 876-883
29. Mégraud, F. (1997). A growing demand for Helicobacter pylori culture in the near future? Ital J Gastroenterol Hepatol 29, 574-576
30. Mégraud, F. & Lehours, P. (2007). Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 20, 280-322
31. Miki, K. (2011). Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method". Proc Jpn Acad, Ser B, Phys Biol Sci 87, 405-414
32. Papatheodoridis, G. V., Sougioultzis, S. & Archimandritis, A. J. (2006). Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review. Clin Gastroenterol Hepatol 4, 130-142
33. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N. & Sibley, R. K. (1991). Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325, 1127-1131
34. Peek, R. M., Jr & Blaser, M. J. (2002). Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2, 28-37
35. Porras, C., Nodora, J., Sexton, R., Ferreccio, C., Jimenez, S., Dominguez, R. L., Cook, P., Anderson, G., Morgan, D. R. & other authors (2013). Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701). Cancer Causes Control 24, 209-215
36. Rugge, M., Genta, R. M. & OLGA Group (2005). Staging gastritis: an international proposal. Gastroenterology 129, 1807-1808
37. Rugge, M., Meggio, A., Pennelli, G., Piscioli, F., Giacomelli, L., De Pretis, G. & Graham, D. Y. (2007). Gastritis staging in clinical practice: the OLGA staging system. Gut 56, 631-636
38. Satoh, K., Osawa, H., Yoshizawa, M., Nakano, H., Hirasawa, T., Kihira, K. & Sugano, K. (2008). Assessment of atrophic gastritis using the OLGA system. Helicobacter 13, 225-229
39. Shak, J. R., Sodikoff, J. B., Speckman, R. A., Rollin, F. G., Chery, M. P., Cole, C. R. & Suchdev, P. S. (2011). Anemia and Helicobacter pylori seroreactivity in a rural Haitian population. Am J Trop Med Hyg 85, 913-918
40. Shiota, S., Mahachai, V., Vilaichone, R. K., Ratanachu-ek, T., Tshering, L., Uchida, T., Matsunari, O. & Yamaoka, Y. (2013). Seroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancer. J Med Microbiol 62, 1571-1578
41. Strebel, K., Rolle-Kampczyk, U., Richter, M., Kindler, A., Richter, T. & Schlink, U. (2010). A rigorous small area modelling-study for the Helicobacter pylori epidemiology. Sci Total Environ 408, 3931-3942
42. Suerbaum, S. & Michetti, P. (2002). Helicobacter pylori infection. N Engl J Med 347, 1175-1186
43. Sugimoto, M. & Yamaoka, Y. (2009). The association of vacA genotype and Helicobacter pylori-related disease in Latin American and African populations. Clin Microbiol Infect 15, 835-842
44. Sugimoto, M., Zali, M. R. & Yamaoka, Y. (2009). The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East. Eur J Clin Microbiol Infect Dis 28, 1227-1236
45. Suzuki, R., Shiota, S. & Yamaoka, Y. (2012). Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect Genet Evol 12, 203-213
46. Tonkic, A., Tonkic, M., Lehours, P. & Mégraud, F. (2012). Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter 17 (Suppl 1), 1-8
47. Torres, L. E., Melián, K., Moreno, A., Alonso, J., Sabatier, C. A., Hernández, M., Bermúdez, L. & Rodríguez, B. L. (2009). Prevalence of vacA, cagA and babA2 genes in Cuban Helicobacter pylori isolates. World J Gastroenterol 15, 204-210
48. Torres, L. E., González, L., Melián, K., Alonso, J., Moreno, A., Hernández, M., Reyes, O., Bermúdez, L., Campos, J. & other authors (2012). EPIYA motif patterns among Cuban Helicobacter pylori CagA positive strains. Biomedica 32, 23-31
49. Tummuru, M. K., Cover, T. L. & Blaser, M. J. (1993). Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 61, 1799-1809
50. Uchida, T., Kanada, R., Tsukamoto, Y., Hijiya, N., Matsuura, K., Yano, S., Yokoyama, S., Kishida, T., Kodama, M. & other authors (2007). Immunohistochemical diagnosis of the cagA-gene genotype of Helicobacter pylori with anti-East Asian CagA-specific antibody. Cancer Sci 98, 521-528
51. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N. & Schlemper, R. J. (2001). Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345, 784-789.
52. van Doorn, L. J., Figueiredo, C., Sanna, R., Plaisier, A., Schneeberger, P., de Boer, W. & Quint, W. (1998). Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 115, 58-66
53. Vilaichone, R. K., Mahachai, V., Tumwasorn, S., Wu, J. Y., Graham, D. Y. & Yamaoka, Y. (2004). Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter 9, 453-459
54. Vilaichone, R. K., Mahachai, V., Shiota, S., Uchida, T., Ratanachu-ek, T., Tshering, L., Tung, N. L., Fujioka, T., Moriyama, M. & Yamaoka, Y. (2013). Extremely high prevalence of Helicobacter pylori infection in Bhutan. World J Gastroenterol 19, 2806-2810
55. Xia, Y., Yamaoka, Y., Zhu, Q., Matha, I. & Gao, X. (2009). A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. PLoS ONE 4, e7736
56. Yamaoka, Y. (2010). Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 7, 629-641
57. Yamaoka, Y., Kodama, T., Kashima, K., Graham, D. Y. & Sepulveda, A. R. (1998a). Variants of the 39 region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol 36, 2258-2263
58. Yamaoka, Y., Kodama, T., Kita, M., Imanishi, J., Kashima, K. & Graham, D. Y. (1998b). Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter 3, 241-253
59. Yamaoka, Y., El-Zimaity, H. M., Gutierrez, O., Figura, N., Kim, J. K., Kodama, T., Kashima, K. & Graham, D. Y. (1999a). Relationship between the cagA 3′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 117, 342-349
60. Yamaoka, Y., Kodama, T., Gutierrez, O., Kim, J. G., Kashima, K. & Graham, D. Y. (1999b). Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 37, 2274-2279
61. Yamaoka, Y., Osato, M. S., Sepulveda, A. R., Gutierrez, O., Figura, N., Kim, J. G., Kodama, T., Kashima, K. & Graham, D. Y. (2000). Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect 124, 91-96
62. Yamaoka, Y., Kikuchi, S., el-Zimaity, H. M., Gutierrez, O., Osato, M. S. & Graham, D. Y. (2002). Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 123, 414-424.